Targeting FACT complex suppresses mammary tumorigenesis in Her2/neu transgenic mice

Cancer Prevention Research

Volumn 5, Issue 8, 2012, Pages 1025-1035

  Koman, Igor E ^a   Commane, Mairead ^a   Paszkiewicz, Geraldine ^a   Hoonjan, Bhupinder ^a   Pal, Srabani ^a   Safina, Alfiya ^a   Toshkov, Ilya ^c   Purmal, Andrei A ^b,c   Wang, Dan ^a   Liu, Song ^a   Morrison, Carl ^a   Gudkov, Andrei V ^a,b,c   Gurova, Katerina V ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Division of Chemistry   (United States)

^c CLEVELAND BIOLABS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CURAXIN 137; DRINKING WATER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG TARGETING; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSGENIC ANIMAL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTIONAL ELONGATION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866521142     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0529     Document Type: Article

References (15)

1. Gasparian AV, Burkhart CA, Purmal AA, Brodsky L, Pal M, Saranadasa M, et al. Curaxins: anticancer compounds that simultaneously suppress NF-{kappa}B and activate p53 by targeting FACT. Sci Transl Med 2011;3:95ra74.
2. Neznanov N, Gorbachev AV, Neznanova L, Komarov AP, Gurova KV, Gasparian AV, et al. Anti-malaria drug blocks proteotoxic stress response: Anticancer implications. Cell Cycle 2009;8: 23297-301.
3. Reinberg D, Sims RJ 3rd. de FACTo nucleosome dynamics. J Biol Chem 2006;281:23297-301.
4. Tan BC, Chien CT, Hirose S, Lee SC. Functional cooperation between FACT and MCM helicase facilitates initiation of chromatin DNA replication. EMBO J 2006;25:3975-85.
5. Zeng SX, Li Y, Jin Y, Zhang Q, Keller DM, McQuaw CM, et al. Structure specific recognition protein 1 facilitates microtubule growth and bundling required for mitosis. Mol Cell Biol 2009;30: 935-47.
6. Saunders A, Werner J, Andrulis ED, Nakayama T, Hirose S, Reinberg D, et al. Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo. Science 2003;301:1094-6.
7. Lucchini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, et al. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Cancer Lett 1992;64: 203-9.
8. Sacco MG, Gribaldo L, Barbieri O, Turchi G, Zucchi I, Collotta A, et al. Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice. Breast Cancer Res Treat 1998;47:171-80.
9. Calogero RA, Cordero F, Forni G, Cavallo F. Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice. Breast Cancer Res 2007;9:211.
10. Li B, Rosen JM, McMenamin-Balano J, Muller WJ, Perkins AS. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol 1997;17:3155-63.
11. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 2001;20:1287-99.
12. Podsypanina K, Li Y, Varmus HE. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. BMC Med 2004;2:24.
13. Gurova KV, Hill JE, Guo C, Prokvolit P, Burdelya L, Samoylova E, et al. Small molecules that reactivate p53 in renal cell carcinoma reveal a NFkappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U S A 2005;102:17448-53.
14. Casalini P, Botta L, Menard S. Role of p53 in HER2-induced proliferation or apoptosis. J Biol Chem 2001;276:12449-53.
15. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000;19:968-88.